Experience

JEITO

• Argentina
• Business Consulting and Services
• 1 - 100 Employee

• Principal

  • Apr 2023 - 9 months

  New York, United States



J.P. Morgan

• United States
• Financial Services
• 700 & Above Employee

• Vice President, Equity Research

  • Jan 2021 - Mar 2023

  New York, United States

• Associate, Equity Research

  • Jun 2018 - Jan 2021

  New York, New York



Piper Jaffray

• United States
• Financial Services
• 300 - 400 Employee

• Equity Research Analyst

  • Jan 2016 - May 2018

  New York Part of a healthcare equity research team covering Large-Cap pharma. Previously covered SMid-Cap Biotech companies.



Princeton University

• United States
• Higher Education
• 700 & Above Employee

• Ph.D

  • 2009 - Jun 2015

  Princeton, NJ Ph.D. Department of Molecular Biology, Princeton University. (August 2009 – June 2015) Advisor: Professor Paul Schedl. I studied the role of chromatin elements called insulators in organizing the 3-dimensional architecture of the chromosome for differential transcriptional outputs. I discovered and elucidated a novel ~700KDa protein complex that regulates the insulator, Fab-7, in a… Show more Ph.D. Department of Molecular Biology, Princeton University. (August 2009 – June 2015) Advisor: Professor Paul Schedl. I studied the role of chromatin elements called insulators in organizing the 3-dimensional architecture of the chromosome for differential transcriptional outputs. I discovered and elucidated a novel ~700KDa protein complex that regulates the insulator, Fab-7, in a developmental and tissue specific manner using genetic manipulations at the endogenous locus, protein purification, gel shift analysis, ChIP Q-PCR, and confocal microscopy. This work was presented at the annual Drosophila research conference and a manuscript is submitted for review. Thesis title : LBC AND ITS ROLE IN DEVELOPMENTAL MODULATION OF INSULATORS IN DROSOPHILA MELANOGASTER

• Graduate Teaching Assistant

  • Feb 2011 - Jan 2015

  Princeton University



LifeSci Capital

• United States
• Investment Banking

• Contract Writer

  • Oct 2014 - Nov 2014

  Contract writer, LifeSci Capital, NYC (October 2014 – November 2014) In assembling an initiation report for the biopharmaceutical company Transgene (TNG), I carried out the due diligence necessary to understand the disease, Hepatocellular carcinoma (HCC). I researched the causes, pathogenesis, diagnosis, and treatments (currently available as well as those in clinical trials) for HCC and then wrote a report, which was presented to the TNG and subsequently… Show more Contract writer, LifeSci Capital, NYC (October 2014 – November 2014) In assembling an initiation report for the biopharmaceutical company Transgene (TNG), I carried out the due diligence necessary to understand the disease, Hepatocellular carcinoma (HCC). I researched the causes, pathogenesis, diagnosis, and treatments (currently available as well as those in clinical trials) for HCC and then wrote a report, which was presented to the TNG and subsequently published at lifescicaptial.com. Show less



Nemours- A.I Dupont Hospital for Children

• Hospital & Health Care
• 1 - 100 Employee

• Research Assistant

  • 2007 - 2009

  Wilmington, Delware Medical Research Assistant. Center for Childhood Cancer Research, Nemours (June 2007 – August 2009) Advisor: Dr. Sigrid Langhans. I studied the effect of the cardiac glycoside, Ouabain on Epidermal growth factor (EGF) signaling as a potential therapeutic agent for Medulloblastoma. The work is published in Cancer Medicine (2014).